Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM9J7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $108,132
Award facts
- Contract value 100% obligated
- $108,131.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $108,131.68 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors. The contract is firm fixed price with an ultimate completion date of January 12, 2026, and represents a non-competitive award under an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order was awarded on January 9, 2026, and falls under the company's broader pharmaceutical distribution operations supporting federal medical procurement needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a separate $999,999,999.00 IDC with DLA Troop Support Medical extending through December 31, 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Dupixent is a biologic medication used to treat atopic dermatitis, asthma, and other allergic conditions, making this order part of DLA's critical supply chain for military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FM9J7?
SPE2DR26FM9J7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FM9J7 worth?
The government has obligated $108,132 on SPE2DR26FM9J7.
Is contract SPE2DR26FM9J7 an order under another contract?
Yes. SPE2DR26FM9J7 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM9J7 competed?
The extent of competition for SPE2DR26FM9J7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award